<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-07T08:16:06Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/4240" metadataPrefix="oai_dc">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/4240</identifier><datestamp>2021-11-10T09:38:19Z</datestamp><setSpec>com_10259_3924</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_3925</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Molecular Interactions of Prodiginines with the BH3 Domain of Anti-Apoptotic Bcl-2 Family Members</dc:title>
<dc:creator>Hossein, Ali</dc:creator>
<dc:creator>Espona Fiedler, Margarita</dc:creator>
<dc:creator>Soto Cerrato, Vanessa</dc:creator>
<dc:creator>Quesada Pato, Roberto</dc:creator>
<dc:creator>Pérez Tomás, Ricardo</dc:creator>
<dc:creator>Guallar, Victor</dc:creator>
<dc:subject>Química orgánica</dc:subject>
<dc:subject>Chemistry, Organic</dc:subject>
<dc:description>Prodigiosin and obatoclax, members of the prodiginines family, are small molecules with anti-cancer properties that are&#xd;
currently under preclinical and clinical trials. The molecular target(s) of these agents, however, is an open question.&#xd;
Combining experimental and computational techniques we find that prodigiosin binds to the BH3 domain in some BCL-2&#xd;
protein families, which play an important role in the apoptotic programmed cell death. In particular, our results indicate&#xd;
a large affinity of prodigiosin for MCL-1, an anti-apoptotic member of the BCL-2 family. In melanoma cells, we demonstrate&#xd;
that prodigiosin activates the mitochondrial apoptotic pathway by disrupting MCL-1/BAK complexes. Computer simulations&#xd;
with the PELE software allow the description of the induced fit process, obtaining a detailed atomic view of the molecular&#xd;
interactions. These results provide new data to understand the mechanism of action of these molecules, and assist in the&#xd;
development of more specific inhibitors of anti-apoptotic BCL-2 proteins.</dc:description>
<dc:description>Spanish government and the European Union (FIS-PI10/00338) and from the ERC-2009-Adg&#xd;
25027-PELE European project.</dc:description>
<dc:date>2016-09-22T09:02:35Z</dc:date>
<dc:date>2016-09-22T09:02:35Z</dc:date>
<dc:date>2013-02</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:identifier>1932-6203</dc:identifier>
<dc:identifier>http://hdl.handle.net/10259/4240</dc:identifier>
<dc:identifier>10.1371/journal.pone.0057562</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>PLoS ONE. 2013, V. 8, n. 2, e57562</dc:relation>
<dc:relation>http://dx.doi.org/10.1371/journal.pone.0057562</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/UE/FIS-PI10/00338</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/EC/FP7/25027</dc:relation>
<dc:rights>Attribution 4.0 International</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:format>application/pdf</dc:format>
<dc:publisher>Public Library of Science</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>